MedTrace Logo

Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea

NCT01070277 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-08-27

No results posted yet for this study

Summary

Study hypotheses is that Antiparasitic therapy in patients with chronic diarrhea after travel to a developing country, with a negative stool findings, will be significantly effective in eliminating diarrhea and other gastro-intestinal complaints compared to similar patients receiving placebo.

Conditions

Interventions

DRUG

Tinidazole and Albendazole

Tinidazole 2 gr/daily for 2 days followed by Albendazole 400mg X2 /day for 7 days

DRUG

Placebo control

2 placebo pills X2 /day for 2 days followed by 1 placebo Pill X2 / day for 7 days

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2015-12-31
Completion
2016-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01070277 on ClinicalTrials.gov